Page last updated: 2024-08-23

1-deoxynojirimycin and Kahler Disease

1-deoxynojirimycin has been researched along with Kahler Disease in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hughes, DA; Mehta, A; Thomas, AS	1
Alonzi, DS; Antonopoulos, A; Butters, TD; Chaidos, A; Danks, L; Dell, A; Dwek, RA; Ersek, A; Freidin, A; Goudevenou, K; Haslam, SM; Hatjiharissi, E; Horwood, NJ; Hu, M; Karadimitris, A; Papaioannou, M; Parry, S; Rahemtulla, A; Roberts, I; Santo, AE; Spanoudakis, E; Twigg, G; Vattakuzhi, Y; Williams, LM; Xu, K	1
Hughes, D	1

Reviews

1 review(s) available for 1-deoxynojirimycin and Kahler Disease

Article	Year
Gaucher disease: haematological presentations and complications. British journal of haematology, 2014, Volume: 165, Issue:4 Topics: 1-Deoxynojirimycin; Anemia; Combined Modality Therapy; Disease Management; Enzyme Replacement Therapy; Gaucher Disease; Genetic Predisposition to Disease; Glucosylceramidase; Glycosphingolipids; Hemorrhagic Disorders; Humans; Inflammation; Lewy Body Disease; Lysosomes; Macrophage Activation; Multiple Myeloma; Parkinson Disease; Splenectomy; Splenomegaly; Thrombocytopenia; Unfolded Protein Response	2014

Article

Year

Gaucher disease: haematological presentations and complications.

British journal of haematology, 2014, Volume: 165, Issue:4

Topics: 1-Deoxynojirimycin; Anemia; Combined Modality Therapy; Disease Management; Enzyme Replacement Therapy; Gaucher Disease; Genetic Predisposition to Disease; Glucosylceramidase; Glycosphingolipids; Hemorrhagic Disorders; Humans; Inflammation; Lewy Body Disease; Lysosomes; Macrophage Activation; Multiple Myeloma; Parkinson Disease; Splenectomy; Splenomegaly; Thrombocytopenia; Unfolded Protein Response

2014

Other Studies

2 other study(ies) available for 1-deoxynojirimycin and Kahler Disease

Article	Year
Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease. The Journal of clinical investigation, 2015, Volume: 125, Issue:6 Topics: 1-Deoxynojirimycin; Animals; Cell Line; CSK Tyrosine-Protein Kinase; Female; Glucosyltransferases; Glycoside Hydrolase Inhibitors; Glycosphingolipids; Insulin-Like Growth Factor I; Membrane Microdomains; Mice; Mice, Knockout; Multiple Myeloma; Osteoclasts; Osteolysis; RANK Ligand; src-Family Kinases; TNF Receptor-Associated Factor 6	2015
Gaucher disease: hematologic and oncologic implications. Clinical advances in hematology & oncology : H&O, 2011, Volume: 9, Issue:10 Topics: 1-Deoxynojirimycin; Carcinoma, Hepatocellular; Enzyme Inhibitors; Enzyme Replacement Therapy; Gaucher Disease; Glucosylceramidase; Glucosyltransferases; Humans; Liver; Multiple Myeloma; Risk Factors; Spleen; Splenectomy	2011

Article

Year

Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease.

The Journal of clinical investigation, 2015, Volume: 125, Issue:6

Topics: 1-Deoxynojirimycin; Animals; Cell Line; CSK Tyrosine-Protein Kinase; Female; Glucosyltransferases; Glycoside Hydrolase Inhibitors; Glycosphingolipids; Insulin-Like Growth Factor I; Membrane Microdomains; Mice; Mice, Knockout; Multiple Myeloma; Osteoclasts; Osteolysis; RANK Ligand; src-Family Kinases; TNF Receptor-Associated Factor 6

2015

Gaucher disease: hematologic and oncologic implications.

Clinical advances in hematology & oncology : H&O, 2011, Volume: 9, Issue:10

Topics: 1-Deoxynojirimycin; Carcinoma, Hepatocellular; Enzyme Inhibitors; Enzyme Replacement Therapy; Gaucher Disease; Glucosylceramidase; Glucosyltransferases; Humans; Liver; Multiple Myeloma; Risk Factors; Spleen; Splenectomy

2011